Financials Transpek Industry Limited

Equities

TRANSPEK6

INE687A01016

Diversified Chemicals

Market Closed - Bombay S.E. 06:00:50 2024-04-26 am EDT 5-day change 1st Jan Change
1,868 INR -1.50% Intraday chart for Transpek Industry Limited +0.78% +4.08%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 6,888 8,393 6,861 7,616 10,895 8,216
Enterprise Value (EV) 1 8,911 9,830 8,117 8,509 11,761 9,436
P/E ratio 26.1 x 12.8 x 9.41 x 32.7 x 16.7 x 9.84 x
Yield 0.73% 1.33% 1.02% 0.55% 1.15% 1.87%
Capitalization / Revenue 1.88 x 1.38 x 1.18 x 2.2 x 1.8 x 0.99 x
EV / Revenue 2.43 x 1.61 x 1.4 x 2.46 x 1.95 x 1.13 x
EV / EBITDA 17 x 7.45 x 6.5 x 17.1 x 11.2 x 5.87 x
EV / FCF -7.03 x 20.8 x 17.4 x 25.5 x -143 x 19.4 x
FCF Yield -14.2% 4.8% 5.76% 3.92% -0.7% 5.14%
Price to Book 2.79 x 2.7 x 2.03 x 2.01 x 2.25 x 1.4 x
Nbr of stocks (in thousands) 5,586 5,586 5,586 5,586 5,586 5,586
Reference price 2 1,233 1,503 1,228 1,363 1,950 1,471
Announcement Date 8/18/18 7/13/19 9/1/20 8/21/21 8/18/22 8/2/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 3,666 6,096 5,793 3,455 6,039 8,338
EBITDA 1 523.9 1,319 1,249 498 1,049 1,607
EBIT 1 424.7 1,178 1,070 303.4 848.3 1,388
Operating Margin 11.58% 19.32% 18.47% 8.78% 14.05% 16.65%
Earnings before Tax (EBT) 1 350.2 1,013 935.2 255.4 842.4 1,128
Net income 1 264 657.4 729.4 233.1 654 834.8
Net margin 7.2% 10.78% 12.59% 6.75% 10.83% 10.01%
EPS 2 47.27 117.7 130.6 41.74 117.1 149.4
Free Cash Flow 1 -1,268 471.7 467.7 333.9 -82.35 485.4
FCF margin -34.6% 7.74% 8.07% 9.66% -1.36% 5.82%
FCF Conversion (EBITDA) - 35.76% 37.45% 67.04% - 30.21%
FCF Conversion (Net income) - 71.76% 64.12% 143.23% - 58.15%
Dividend per Share 2 9.000 20.00 12.50 7.500 22.50 27.50
Announcement Date 8/18/18 7/13/19 9/1/20 8/21/21 8/18/22 8/2/23
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q4
Net sales 1 1,427
EBITDA 1 163.3
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date 6/13/22
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 2,024 1,437 1,256 894 866 1,220
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.863 x 1.09 x 1.006 x 1.794 x 0.8259 x 0.7591 x
Free Cash Flow 1 -1,268 472 468 334 -82.4 485
ROE (net income / shareholders' equity) 11.7% 23.5% 22.4% 6.49% 15.1% 15.6%
ROA (Net income/ Total Assets) 5.57% 12.6% 11.2% 3.19% 7.78% 10.5%
Assets 1 4,740 5,203 6,487 7,303 8,409 7,941
Book Value Per Share 2 442.0 558.0 606.0 680.0 867.0 1,050
Cash Flow per Share 2 1.180 0.4600 0.7200 27.70 2.860 9.840
Capex 1 1,195 478 374 175 477 493
Capex / Sales 32.59% 7.84% 6.45% 5.08% 7.9% 5.91%
Announcement Date 8/18/18 7/13/19 9/1/20 8/21/21 8/18/22 8/2/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TRANSPEK6 Stock
  4. Financials Transpek Industry Limited